Literature DB >> 2473637

Stimulation of histamine release by the peptide kinetensin.

A Sydbom1, J Ware, M H Mogard.   

Abstract

The peptide kinetensin isolated from pepsin-treated human plasma induced a dose-dependent release of histamine when exposed to rat peritoneal mast cells. The threshold concentration was around 10(-6) M, the ED50 was 10(-5) M, and the optimal concentration of between 10(-4) to 10(-3) M released 80% of the total histamine. Kinetensin was 10 to 100 times less potent than neurotensin and equipotent with the opioid peptide dynorphin. The histamine release was clearly temperature-dependent, with no release occurring at 0 degrees or 45 degrees C and with an optimum around 37 degrees C. The histamine release was significantly reduced in the absence of extracellular calcium. Kinetensin also induced a dose-dependent increase in vascular permeability when injected intradermally into rats. The findings indicate that kinetensin is a potent histamine releaser in the rat and may serve as an inflammatory mediator.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473637     DOI: 10.1007/bf02222201

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  10 in total

1.  The amino acid sequence of kinetensin, a novel peptide isolated from pepsin-treated human plasma: homology with human serum albumin, neurotensin and angiotensin.

Authors:  M H Mogard; R Kobayashi; C F Chen; T D Lee; J R Reeve; J E Shively; J H Walsh
Journal:  Biochem Biophys Res Commun       Date:  1986-05-14       Impact factor: 3.575

2.  Mast cell activation--a receptor-independent mode of substance P action?

Authors:  H Repke; M Bienert
Journal:  FEBS Lett       Date:  1987-09-14       Impact factor: 4.124

3.  Action of the SP2-11 and SP3-11 fragments of substance P on rat peritoneal mast cells.

Authors:  W Piotrowski; M Mead; J C Foreman
Journal:  Agents Actions       Date:  1987-04

4.  Characteristics of beta-endorphin-induced histamine release from rat serosal mast cells. Comparison with neurotensin, dynorphin and compound 48/80.

Authors:  A Sydbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

5.  Release of histamine from mast cells by vasoactive peptides.

Authors:  A R Johnson; E G Erdös
Journal:  Proc Soc Exp Biol Med       Date:  1973-04

6.  The histamine-releasing effect of dynorphin and other peptides possessing Arg-Pro sequences.

Authors:  A Sydbom; L Terenius
Journal:  Agents Actions       Date:  1985-04

7.  Neurotensin-like immunoreactivity generated by pepsin from human plasma and gastric tissue.

Authors:  M H Mogard; R Kobayashi; T D Lee; C F Chen; M Hagiwara; F Leung; J R Reeve; J E Shively; J H Walsh
Journal:  Regul Pept       Date:  1987-08-17

8.  Peptides and histamine release from rat peritoneal mast cells.

Authors:  P Devillier; M Renoux; J P Giroud; D Regoli
Journal:  Eur J Pharmacol       Date:  1985-10-29       Impact factor: 4.432

9.  On the mechanism by which theophylline inhibits histamine release from rat mast cells.

Authors:  A Sydbom; B B Fredholm
Journal:  Acta Physiol Scand       Date:  1982-02

10.  Histamine release by neurotensin in the rat hindquarter: structure-activity studies.

Authors:  R Kerouac; S St-Pierre; F Rioux
Journal:  Peptides       Date:  1984 Jul-Aug       Impact factor: 3.750

  10 in total
  2 in total

1.  Pharmacokinetics and biological activity of kinetensin in conscious sheep.

Authors:  D Read; A Shulkes; D Fletcher; K Hardy
Journal:  Agents Actions       Date:  1993-03

2.  Histamine secretion induced by neuromedin-N.

Authors:  A Sydbom; J Ware; I Schultz; M H Mogard
Journal:  Agents Actions       Date:  1990-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.